ConductScience.org, home

Comparison · NCT02100722-3ad7aa32

FFR Guided PCI vs CABG: Number of Participants Experiencing Death, MI, or Stroke

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. FFR Guided PCI vs CABG: Number of Participants Experiencing Death, MI, or Stroke. Trial comparisons, record NCT02100722-3ad7aa32. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02100722-3ad7aa32

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.07270.05620.0934wilson
Risk in group 20.05250.03860.071wilson
Risk difference, group 1 minus group 20.0202-0.004540.0451newcombe hybrid score
Risk ratio, group 1 over group 21.380.932.06log
Odds ratio, group 1 over group 21.410.9262.16log
Number needed to treat, for one more participant with the outcome on FFR Guided PCI than on CABG49.6from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1FFR Guided PCIPatients undergoing PCI with measured FFR ≤0.80 have PCI performed with Medtronic Resolute Integrity (or Onyx) drug-eluting stent.55757OG000
Group 2CABGCABG performed per clinical routine (both off-pump and on-pump surgery acceptable).39743OG001

Outcome

Type
SECONDARY
Title
Number of Participants Experiencing Death, MI, or Stroke
Description
Subjects who died or are lost to follow up before this time were censored at their last recorded activity.
Time frame
1 year
Population

Source ClinicalTrials.gov

Trial

Title
A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
NCT number
NCT02100722
Phases
NA
Conditions
Coronary Disease, Coronary Stenosis
Interventions
FFR guided PCI, CABG, Resolute Integrity Stent, Resolute Onyx Stent
Lead sponsor
Stanford University
Results first posted
2022-01-20

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02100722-3ad7aa32